Loading clinical trials...
Loading clinical trials...
This study was designed to evaluate the safety and efficacy of Cesamet™ in controlling pain in subjects experiencing pain due to chemotherapy-induced neuropathic pain in patients with cancer.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
NEMA Research, Inc.
NCT06614322 · Painful Peripheral Neuropathy, Diabetic Peripheral Neuropathic Pain (DPN), and more
NCT07260656 · Diabetic Neuropathies, Painful, Diabetic Foot, and more
NCT07072468 · Chemotherapy-induced Peripheral Neuropathy, Drug-Induced Nephropathy
NCT07423390 · Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathy, Chemotherapy-induced
NCT06769061 · Gynaecological, Urological or Rectal Cancer, Chemotherapy-Induced Peripheral Neuropathy, and more
South Florida Medical Research
Aventura, Florida
Naples Anesthesia and Pain Associates
Naples, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions